Nostrum Says Ch. 11 Trustee Unnecessary

By Emily Lever · October 15, 2024, 6:57 PM EDT

New Jersey drugmaker Nostrum Laboratories has filed an opposition to Citizens Bank's motion to appoint a Chapter 11 trustee, arguing it was filed too early and is unneeded because Nostrum plans...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Response

Case Information

Case Title

Nostrum Laboratories, Inc.

Case Number

Court

New Jersey

Nature of Suit

Date Filed

September 30, 2024

Recent Articles By Emily

October 17, 2024
NJ Injury Firm Heads To Ch. 11 Under $700K State Tax Debt
October 16, 2024
Profs Urge 3rd Circ. To Rethink Reopening Shipbuilder Ch. 11
October 11, 2024
Wheel-Maker Can Tap $20M Of $103M Ch. 11 Funding
October 10, 2024
Biotech Co. Gritstone Hits Ch. 11 With Over $100M Debt
October 09, 2024
Sanctioned NJ Firm Asks To Exit $374M Guo Ch. 11
October 08, 2024
How Hasty Purchases Drove Wheel Pros Into Ch. 11
October 07, 2024
Vendor Says Rue21 Skipped $2M In Bills For Clothing
September 09, 2024
Automotive Co. Wheel Pros Hits Ch. 11 With Over $1B In Debt
September 06, 2024
US Trustee Says Solar Biotech Sale Price May Be Too Low
September 05, 2024
Asbestos Claimants Want A Say In 4th Circ. 'Two-Step' Appeal